A citation-based method for searching scientific literature

Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan, Hanno B Richards, Shephard Mpofu. N Engl J Med 2015
Times Cited: 486

Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd-Ruediger Burmester, David H Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark Genovese. Lancet 2017
Times Cited: 219

List of shared articles

Times cited

Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Frank Kolbinger, Franco Di Padova, Atul Deodhar, Jason E Hawkes, Christine Huppertz, Torsten Kuiper, Iain B McInnes, Christopher T Ritchlin, David Rosmarin, Georg Schett,[...]. Pharmacol Ther 2022

Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis.
Gian Luca Erre, Dimitris Mavridis, Richard John Woodman, Arduino Aleksander Mangoni. Rheumatology (Oxford) 2022

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.
Iain B McInnes, Laura M Sawyer, Kristen Markus, Corinne LeReun, Celia Sabry-Grant, Philip S Helliwell. RMD Open 2022


Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial.
Kristian Reich, Lars Erik Kristensen, Saxon D Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham. Dermatol Pract Concept 2022

Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms.
Hoi Ki Joshua Tam, Philip C Robinson, Peter Nash. Curr Rheumatol Rep 2022

Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis.
Zhenyu Zhong, Guannan Su, Aize Kijlstra, Peizeng Yang. Prog Retin Eye Res 2021

Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Alexis Ogdie, Peter Hur, Mei Liu, Sabrina Rebello, Robert R McLean, Blessing Dube, Meghan Glynn, Philip J Mease. J Rheumatol 2021

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2.
Philip J Mease, Apinya Lertratanakul, Jaclyn K Anderson, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro Keiserman, Xin Wang, Sheng Zhong,[...]. Ann Rheum Dis 2021

Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers.
Solveig Skovlund Groen, Dovile Sinkeviciute, Anne-Christine Bay-Jensen, Christian S Thudium, Morten A Karsdal, Simon Francis Thomsen, Georg Schett, Signe Holm Nielsen. Autoimmun Rev 2021

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities.
Alan Menter, Gerald G Krueger, So Yeon Paek, Dario Kivelevitch, Iannis E Adamopoulos, Richard G Langley. Dermatol Ther (Heidelb) 2021

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021

Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis.
Mariana Garcia-Leal, Mayra A Reyes-Soto, Ivan Hernandez-Galarza, Neri A Alvarez-Villalobos, Dionicio A Galarza-Delgado, Diana E Flores-Alvarado. Clin Rheumatol 2021

Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals.
R Diel, T Schaberg, A Nienhaus, R Otto-Knapp, C Kneitz, A Krause, M Fabri, U Mrowietz, T Bauer, B Häcker. Pneumologie 2021

Interleukin-17A Interweaves the Skeletal and Immune Systems.
Mengjia Tang, Lingyun Lu, Xijie Yu. Front Immunol 2021

Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.
Rosario García-Vicuña, Noemí Garrido, Susana Gómez, Beatriz Joven, Rubén Queiro, Julio Ramírez, Francisco Rebollo, Estíbaliz Loza, Agustí Sellas. Rheumatol Int 2021

JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials.
Stephanie Keeling, Walter P Maksymowych. Expert Rev Clin Immunol 2021

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study.
Philip J Mease, Saima Chohan, Ferran J Garcia Fructuoso, Michael E Luggen, Proton Rahman, Siba P Raychaudhuri, Richard C Chou, Alan M Mendelsohn, Stephen J Rozzo, Alice Gottlieb. Ann Rheum Dis 2021

Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI).
Anne Tournadre, Jérémie Sellam, Jacques Morel, Denis Jullien, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle-Pensec, Philippe Goupille, Nicolas Kluger, Estibaliz Lazaro,[...]. Joint Bone Spine 2021

The heterogeneous human memory CCR6+ T helper-17 populations differ in T-bet and cytokine expression but all activate synovial fibroblasts in an IFNγ-independent manner.
Wendy Dankers, Hannah den Braanker, Sandra M J Paulissen, Jan Piet van Hamburg, Nadine Davelaar, Edgar M Colin, Erik Lubberts. Arthritis Res Ther 2021

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
Angela Ceribelli, Francesca Motta, Matteo Vecellio, Natasa Isailovic, Francesco Ciccia, Carlo Selmi. Front Immunol 2021

Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases.
Shintaro Akiyama, Atsushi Sakuraba. J Transl Autoimmun 2021

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis.
Ettore Silvagni, Sonia Missiroli, Mariasole Perrone, Simone Patergnani, Caterina Boncompagni, Alessandra Bortoluzzi, Marcello Govoni, Carlotta Giorgi, Stefano Alivernini, Paolo Pinton,[...]. Front Pharmacol 2021

Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor?
Jinxian Huang, Lijun Zhang, James C-C Wei. Int J Rheum Dis 2021

Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries.
Philip G Conaghan, Dorothy L Keininger, Elizabeth A Holdsworth, Nicola Booth, Niraj N Modi, Haijun Tian, Uta Kiltz. Curr Med Res Opin 2021

Targeted Therapies in Axial Psoriatic Arthritis.
Alberto Floris, Mattia Congia, Elisabetta Chessa, Maria Maddalena Angioni, Matteo Piga, Alberto Cauli. Front Genet 2021

Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis.
Dalifer Freites Nuñez, Alfredo Madrid-García, Leticia Leon, Gloria Candelas, Mercedes Núñez, Natalia Bello, Silvia Díaz, Benjamín Fernández-Gutiérrez, Lydia Abasolo, Luis Rodriguez-Rodriguez. Rheumatol Ther 2021

Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis.
Steven L Truong, Jasmine Chin, David F L Liew, Syeda Farah Zahir, Elizabeth G Ryan, Diana Rubel, Graham Radford-Smith, Philip C Robinson. Rheumatol Ther 2021

Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints.
Janne W Bolt, Chaja M J van Ansenwoude, Ihsan Hammoura, Marleen G van de Sande, Lisa G M van Baarsen. Front Med (Lausanne) 2021